US Stock Market Today: S&P 500 Futures Edge Higher As Inflation Concerns Meet Weak Sentiment

The Morning Bull – US Market Morning Update Monday, Oct, 12 2026

US stocks are set for a cautious open, with sentiment pulled in two directions by inflation worries and weakening consumers. The dominant driver today is the jump in US inflation expectations that clashes with a sharp slide in confidence.

The University of Michigan survey shows year ahead inflation expectations at 4.7% in October and the five year view at 3.5%. At the same time, consumer sentiment has dropped to 46.3, the weakest reading in five months and alongside a record low in current conditions.

Higher expected inflation raises the risk that borrowing costs stay elevated for longer. This pressures valuations for rate sensitive areas and complicates refinancing. A bruised consumer backdrop, reflected in the sentiment data, also clouds revenue assumptions for companies that rely heavily on discretionary spending.

The unresolved question is which signal the Federal Reserve leans into next: sticky inflation expectations or fragile households. That debate meets a packed week of CPI, PPI and retail sales, where each print could either validate today’s concern or force a quick rethink.

Stocks to Watch Before the Opening Bell

Tesla (TSLA)

Fresh Cybertruck data puts Tesla’s latest bet under the microscope. Third quarter estimates point to only 7,000 to 8,000 units, or an annualized 28,000 to 32,000 trucks, compared with Elon Musk’s 250,000 goal. Interest has cooled since early deliveries. Upcoming competition from Ford’s lower priced Fathom EV truck adds pressure on pricing power and demand.

Amazon.com (AMZN)

Talks to buy Decart AI for about US$7b give Amazon.com another potential lever in the chip race. Decart’s software helps developers switch between chips more efficiently, which lines up with efforts to get more out of Amazon’s Trainium processors. Investors will watch whether the deal closes and whether rival bidders emerge, which could shape terms and timing.

Citigroup (C)

Fresh commentary from Citigroup is putting Treasury issuance in focus rather than bank earnings. The firm expects the US Treasury to cut US$3b from each 20 year and 30 year bond auction and lean more on short term bills. Citi also flags a possible cancellation of the 20 year bond, with details expected on 4 November, which could influence long term yields.

Top Movers

• Crown Castle (CCI) jumped 15.60% after SpaceX’s 800 MHz spectrum deal highlighted potential tower leasing demand.

• Moderna (MRNA) climbed 14.21% as the NIH cancer vaccine initiative and index inclusion fueled biotech enthusiasm.

• Humana (HUM) advanced 11.56% after improved Medicare Advantage star ratings and analyst upgrades reset earnings expectations.

Top Losers

• T-Mobile US (TMUS) fell 13.27% after SpaceX’s spectrum deal and store closure plans refocused attention on competition.

• AT&T (T) declined 10.82% as investors weighed price hikes, new iPhone Duo promotions and SpaceX wireless ambitions.

• AST SpaceMobile (ASTS) fell 10.48% following mixed read-throughs from FCC agenda items and SpaceX spectrum purchases.

On The Radar

Inflation data and a flood of US bank earnings sit at the center of the next few sessions, with each print feeding directly into rate expectations and the health of household spending.

• US CPI and Core CPI Wed 14 Oct. Headline inflation is projected at 3.6% YoY with core at 2.5%. A result above those marks would harden expectations that borrowing costs stay higher for longer and pressure rate sensitive stocks.

• US PPI and Core PPI Thu 15 Oct. Producer prices are forecast to rise 0.5% on the month with core at 0.3%. A hotter read would point to upstream cost pressure that can squeeze margins for manufacturers and retailers.

• US Retail Sales Thu 15 Oct. Overall spending is expected to grow 0.3% MoM with ex autos at 0.5%. A result below those levels would underline the weak sentiment readings and raise questions for consumer discretionary shares.

• US Industrial Production Fri 16 Oct. Output is seen rising 0.3% after a flat prior month. Any shortfall would reinforce concerns about manufacturing momentum and capex plans for cyclical sectors.

• JPMorgan Chase Tue 13 Oct. Q3 results are scheduled for 6:45 AM Eastern, with the focus on credit costs and deposit trends, which signal how tighter financial conditions are filtering through to households and corporate borrowers.

Sector & Industry Watch

Consumer Discretionary: Weak sentiment meets mixed spending data

Consumer Discretionary has logged a solid 7 day gain even though 1 year and year to date returns remain in the red. That fits with what the Michigan survey is hinting at. Households feel gloomy, yet are still spending selectively with Amazon.com deal headlines, travel and dining stories all pulling in different directions.

For your portfolio, that can mean wider gaps between winners tied to everyday purchases and brands reliant on big financed buys. The key data point now is Thursday’s US Retail Sales report, which will show whether spending is holding up or starting to follow sentiment lower.

Energy: Oil resilience keeps cash flow in focus

Energy and the Oil and Gas group have both notched firm 7 day gains, helped by still elevated crude prices and company updates like insider buying at Mach Natural Resources. High pump prices feed directly into fuel bills for drivers and airlines, while producers benefit from stronger cash generation.

Anyone holding this sector is effectively tied to the oil tape and US inventory data. The next catalyst is Wednesday’s API and Thursday’s EIA crude stock reports, which will shape views on whether supply remains tight or starts to loosen.

Tech: AI giants steady after headline swirl

Tech has edged lower over the past week despite strong year to date performance, as investors digest a fresh round of AI stories around Apple, Amazon.com and Nvidia. Leadership changes at Apple, Amazon’s Decart talks and ongoing AI commentary around Nvidia keep enthusiasm high but also remind markets how concentrated some of this theme has become.

If you own broad Tech exposure, your returns are heavily linked to a small group of mega platforms and chip designers. The single event to watch here is Taiwan Semiconductor’s earnings on Thursday, which should give a cleaner read on chip orders behind current AI and smartphone demand.

Financials: Big bank earnings face rate and credit test

Financials have picked up modestly over the last week after a weaker month, with the Banks subgroup roughly flat on a 7 day view. Headlines around Citigroup’s Treasury issuance call, WEX’s payments partnership and analyst moves on firms like T. Rowe Price and Moelis show how split the picture is between lending, trading and fee businesses.

For everyday investors, that mix matters because bank results influence everything from deposit rates to credit availability. The main catalyst now is the start of US bank earnings from JPMorgan, Bank of America, Citi and peers, where commentary on loan demand and deposit costs will help clarify how higher inflation expectations are feeding through to the real economy.

Healthcare & Pharma/Biotech: Research headlines back defensive appeal

Healthcare and Pharmaceuticals & Biotech have climbed over the past week, supported by a steady run of research news from companies like AbbVie, Freenome, Mirum and Johnson & Johnson. These updates focus on cancer screening, inflammatory disease and rare liver conditions, which are driven more by medical need than by day to day economic data.

If you hold this area as a stabiliser in a portfolio, this kind of pipeline news helps explain why the sector often trades differently to consumer or cyclical groups. The key near term check is earnings from UnitedHealth and Johnson & Johnson, which will show how care costs and pricing are tracking against an inflation backdrop that has households feeling under pressure.

How To Find Stocks That Fit Your Strategy

If stubborn inflation expectations and higher for longer rates are your focus, start your next move with this list of 31 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com